23andMe to Go Public With Richard Branson-Backed SPAC
1 minuto de lectura
DNA-testing firm 23andMe is teaming up with a blank-check company backed by British billionaire Richard Branson’s Virgin Group, amid a wave of public-market debuts through special-purpose acquisition companies.DNA-testing firm 23andMe is teaming up with a blank-check company backed by British billionaire Richard Branson’s Virgin Group, amid a wave of public-market debuts through special-purpose acquisition companies.
Read MorePAIDWSJ.com: US Business
Descubre más desde Espacioteca
Suscríbete y recibe las últimas entradas en tu correo electrónico.